Search Results
Oct 14, 2025, 16:18 ET S&T BANK HONORED WITH NATIONAL ABA FOUNDATION COMMUNITY COMMITMENT AWARD
Pa., Oct. 14, 2025 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp, Inc. (NASDAQ, STBA), is announcing its naming as a 2025 American Bankers Association (ABA) Foundation Community Commitment Award recipient in the Supporting Military Families
More news about: S&T Bank
Oct 09, 2025, 18:56 ET Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
HERZUMA® (trastuzumab-pkrb), VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (Ustekinumab-stba) STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), and OMLYCLO® (omalizumab-igec) as well as a novel biologic
More news about: Celltrion
Oct 02, 2025, 08:30 ET Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
HERZUMA® (trastuzumab-pkrb), VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (Ustekinumab-stba) STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), and OMLYCLO® (omalizumab-igec), as well as the novel
More news about: Celltrion
Oct 01, 2025, 12:04 ET S&T Bancorp, Inc. to Host Third Quarter Earnings Conference Call and Webcast
INDIANA, Pa., Oct. 1, 2025 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced today that a conference call detailing the company's third quarter 2025 earnings will be held live
More news about: S&T Bancorp, Inc.
Sep 24, 2025, 15:57 ET S&T BANCORP, INC. ANNOUNCES BOARD OF DIRECTORS LEADERSHIP TRANSITION
Pa., Sept. 24, 2025 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, today announced that Christine J. Toretti, chair of the board of directors of
More news about: S&T Bancorp, Inc.